Your browser doesn't support javascript.
loading
Preclinical and clinical evidence for suppression of alcohol intake by apremilast.
Grigsby, Kolter B; Mangieri, Regina A; Roberts, Amanda J; Lopez, Marcelo F; Firsick, Evan J; Townsley, Kayla G; Beneze, Alan; Bess, Jessica; Eisenstein, Toby K; Meissler, Joseph J; Light, John M; Miller, Jenny; Quello, Susan; Shadan, Farhad; Skinner, Michael; Aziz, Heather C; Metten, Pamela; Morrisett, Richard A; Crabbe, John C; Roberto, Marisa; Becker, Howard C; Mason, Barbara J; Ozburn, Angela R.
Afiliación
  • Grigsby KB; Portland Alcohol Research Center, Department of Behavioral Neuroscience, Oregon Health & Science University, and VA Portland Health Care System, Portland, Oregon, USA.
  • Mangieri RA; Waggoner Center for Alcohol and Addiction Research, Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA.
  • Roberts AJ; Animal Models Core Facility, The Scripps Research Institute, La Jolla, California, USA.
  • Lopez MF; Charleston Alcohol Research Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Firsick EJ; Portland Alcohol Research Center, Department of Behavioral Neuroscience, Oregon Health & Science University, and VA Portland Health Care System, Portland, Oregon, USA.
  • Townsley KG; Portland Alcohol Research Center, Department of Behavioral Neuroscience, Oregon Health & Science University, and VA Portland Health Care System, Portland, Oregon, USA.
  • Beneze A; Pearson Center for Alcoholism and Addiction Research, Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, USA.
  • Bess J; Pearson Center for Alcoholism and Addiction Research, Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, USA.
  • Eisenstein TK; Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
  • Meissler JJ; Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
  • Light JM; Oregon Research Institute, Eugene, Oregon, USA.
  • Miller J; Pearson Center for Alcoholism and Addiction Research, Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, USA.
  • Quello S; Pearson Center for Alcoholism and Addiction Research, Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, USA.
  • Shadan F; Pearson Center for Alcoholism and Addiction Research, Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, USA.
  • Skinner M; Pearson Center for Alcoholism and Addiction Research, Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, USA.
  • Aziz HC; Waggoner Center for Alcohol and Addiction Research, Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA.
  • Metten P; Portland Alcohol Research Center, Department of Behavioral Neuroscience, Oregon Health & Science University, and VA Portland Health Care System, Portland, Oregon, USA.
  • Morrisett RA; Waggoner Center for Alcohol and Addiction Research, Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA.
  • Crabbe JC; Portland Alcohol Research Center, Department of Behavioral Neuroscience, Oregon Health & Science University, and VA Portland Health Care System, Portland, Oregon, USA.
  • Roberto M; Charleston Alcohol Research Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Becker HC; Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Mason BJ; RHJ Department of Veterans Affairs Medical Center, Charleston, South Carolina, USA.
  • Ozburn AR; Pearson Center for Alcoholism and Addiction Research, Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, USA.
J Clin Invest ; 133(6)2023 03 15.
Article en En | MEDLINE | ID: mdl-36656645
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Psoriasis / Alcoholismo / Inhibidores de Fosfodiesterasa 4 Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Psoriasis / Alcoholismo / Inhibidores de Fosfodiesterasa 4 Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos